These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 20078390)
21. [Treatment of lower limb ischemia with combination of traditional Chinese medicine and transplantation of autologous bone marrow mononuclear cells: a report of 23 cases]. Yang BH; Qin JH; Zhu LQ; Chen L; Lu H; Liu FT; Li YS Zhong Xi Yi Jie He Xue Bao; 2005 Jan; 3(1):28-30. PubMed ID: 15644156 [TBL] [Abstract][Full Text] [Related]
22. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453 [TBL] [Abstract][Full Text] [Related]
23. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483 [TBL] [Abstract][Full Text] [Related]
24. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia. Moazzami K; Majdzadeh R; Nedjat S Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427 [TBL] [Abstract][Full Text] [Related]
25. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
26. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia. Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241 [TBL] [Abstract][Full Text] [Related]
27. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial. Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194 [TBL] [Abstract][Full Text] [Related]
28. [Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder]. Yang XF; Wu YX; Wang HM; Xu YF; Lü X; Zhang YB; Wang F; Zhang Y Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):95-8. PubMed ID: 15840218 [TBL] [Abstract][Full Text] [Related]
29. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941 [TBL] [Abstract][Full Text] [Related]
30. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis. Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515 [TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of Repeated Bone Marrow Mononuclear Cell Therapy in Patients with Critical Limb Ischemia in a Pilot Randomized Controlled Trial. Molavi B; Zafarghandi MR; Aminizadeh E; Hosseini SE; Mirzayi H; Arab L; Baharvand H; Aghdami N Arch Iran Med; 2016 Jun; 19(6):388-96. PubMed ID: 27293053 [TBL] [Abstract][Full Text] [Related]
32. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation. Aksu T; Ok Bozkaya İ; Akpınar Tekgündüz S; Olcar Kanbur M; Köksal Y; Özgüner M; Özbek NY Transfus Apher Sci; 2017 Dec; 56(6):829-831. PubMed ID: 29153311 [TBL] [Abstract][Full Text] [Related]